Papanicolaou smear 5-year retrospective review: what is required by the Clinical Laboratory Improvement Amendments of 1988?
Five-year retrospective review of negative or normal smears in patients with newly diagnosed high-grade squamous intraepithelial lesions or cancer is a federal regulation for all laboratories practicing gynecologic cytology under the Clinical Laboratory Improvement Amendments of 1988. Amended reports are required when significant discrepancies are found that would affect patient care. The focus of this regulation is current patient care. Two studies have found a retrospective discrepancy rate of about 10% when the threshold for discrepancy was at least dysplasia. Higher rates are reported when missed atypical cases are counted as discrepancies. Retrospective review highlights problem areas for laboratory education and quality improvement efforts, but liability concerns have been a detrimental consequence of this regulation. Clarification that amended reports be issued only when current patient care is affected should aid laboratories in complying with this regulation.
Davey
D D
DD
Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center, Lexington 40536-0093, USA.
D005161:Facility Regulation and Control / Q000331:legislation & jurisprudence* / Q000592:standards; D005260:Female; D006801:Humans; D065006:Papanicolaou Test; D010338:Pathology, Clinical / Q000331:legislation & jurisprudence* / Q000592:standards; D011785:Quality Assurance, Health Care / Q000331:legislation & jurisprudence* / Q000592:standards; D012189:Retrospective Studies; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000473:pathology; D014626:Vaginal Smears / Q000592:standards*; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis* / Q000473:pathology